Identifies inherited health conditions to enable early intervention and preventive care.
Oncology Diagnostics
Provides molecular profiling to match cancer patients with the most effective, personalized treatment options, improving clinical outcome.
Pharmacogenomics
Analyzes genetic markers to prevent adverse drug reactions and optimize therapy selection based on each patient’s unique genetic makeup.
Prenatal Screening
Offers non-invasive early-pregnancy tests to assess fetal health and detect potential genetic disorders.
Rare Disease Diagnosis
Utilizes a proprietary polygenic risk score, developed specifically for the Saudi population, to enhance diagnostic accuracy and enable targeted treatment strategies.
Clinical Research Support
Supplies genomic data, analytics, and related services to accelerate clinical and academic research, with plans to expand offerings to pharmaceutical companies.
Saudi Biotech company focused on localizing and applying technologies in genomics & multi-omics.